A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

The Janus Henderson Concentrated Growth Managed Account Portfolio returned 2.44% (gross) and the Russell 1000® Growth Index ...

Weight-loss injections slash alcohol cravings and curb heavy drinking by almost half, new research revealed. The JAMA Psychiatry study showed a weekly jab of semaglutide, also known as brand names ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Shortly after Hims & Hers aired its controversial Super Bowl ad promoting its compounded GLP-1 offerings, Novo Nordisk has ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...